Purchase Order AG32SDP160133
- Not listed
- The U.S. Department of Commerce's Pacific West Area office awarded a $16,246.40 firm fixed-price purchase order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on June 16, 2021, with an ultimate completion date of July 16, 2021. This contract, classified as an MSD Assay procurement, was issued without a small business set-aside. Meso Scale Diagnostics, a Native American-owned small business headquartered in Rockville, Maryland, will perform the work at its Davis,...
- The U.S. civilian federal agency within the Pacific West Area awarded a $5,000 firm fixed-price purchase order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on July 6, 2015, for a Discovery Workbench 4.0 upgrade. The contract was completed by July 31, 2015, with no small business set-aside designation. Meso Scale Diagnostics, a Native American-owned small business headquartered in Rockville, Maryland, specializes in advanced biomedical research technologies, particularly...
- The U.S. government awarded a purchase order valued at $12,927.50 to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery), a Native American-owned small business based in Rockville, Maryland. The contract, issued under references K15173-5 and K151RPD-5 by the Pacific West Area civilian agency, was awarded on April 3, 2020, with a completion date of April 30, 2020. This firm fixed-price purchase order was awarded without a set-aside designation and will be performed in Potomac,...
- Meso Scale Diagnostics LLC, a Native American-owned small business based in Rockville, Maryland and operating as Meso Scale Discovery, was awarded a $4,534.25 firm fixed price purchase order on July 26, 2016, for V-PLEX custom human cytokine assay products. The contract, which was not set aside for any small business category, is scheduled for completion by September 30, 2016, with performance taking place in Davis, California. The funding agency is a civilian component of the Pacific West...
- The Food and Drug Administration (FDA) awarded a Purchase Order contract to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on March 8, 2016, with a ceiling value of $80.5K for the PR2 Model 1800, Package C Instrument, Shipping and Service Package. The contract was set aside for total small business and utilized firm fixed pricing. Performance was scheduled to take place in Potomac, Maryland, with an ultimate completion date of May 9, 2017. Meso Scale Diagnostics, a Native...
- The U.S. Defense Department, through the Washington Headquarters Service, awarded a $34.5K firm fixed-price purchase order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on May 1, 2025, for the MSD QuickPlex PM product line. The contract will be performed in Dahlgren, Virginia, with completion targeted for April 30, 2026. This award does not utilize a small business set-aside, despite the vendor being a Native American-owned small business based in Rockville, Maryland....
- Meso Scale Diagnostics LLC, a Native American-owned small business based in Rockville, Maryland, was awarded a $24,067 firm fixed-price purchase order by the U.S. Department of Agriculture's Northeast Area on January 27, 2016. The contract calls for the delivery of V-PLEX Vascular Injury Panel 2 K15198D-4 assay kits (25 pack) to the place of performance in Calverton, Maryland, with an ultimate completion date of March 28, 2016. The award was made on an unrestricted, full and open competitive...
- This is a purchase order issued by the Department of Health and Human Services Centers for Disease Control and Prevention to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, a limited liability company that is Native American owned. The $157,594.00 firm fixed-price contract is for the delivery of lab supplies. No set-aside was used for this award. Meso Scale Diagnostics is a provider of assay development services, laboratory testing equipment, immunoassays, multiplex assay...
- This is a federal purchase order award from the U.S. Department of Health and Human Services (HHS) to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, a small business limited liability company. The award, valued at $12,301.69, is for a product or service described as "MESO SCALE 2 EICH" with a completion date of September 29, 2007. The contract has a firm fixed-price pricing type and does not utilize a small business set-aside. Meso Scale Diagnostics is a provider...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, a civilian agency, to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery. The $195,205 contract is for the delivery of "MESO SCALE PLATES" by September 19, 2024. Meso Scale Diagnostics is a small business that specializes in assay development, laboratory equipment, and multiplex immunoassay products to support biomedical research and testing,...
The U.S. civilian government agency Pacific West Area awarded a $15,606.80 purchase order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on January 28, 2016, with a completion date of February 19, 2016. The contract, issued under firm fixed pricing with no small business set-aside, procures a Meso Scale Discovery N45CA-1 Multi-Spot 96 4-Spot Custom Human B2M assay platform for delivery to Potomac, Maryland. Meso Scale Diagnostics is a Native American-owned small business based in Rockville, Maryland, specializing in electrochemiluminescence-based detection platforms and advanced biomedical research technologies. The company serves federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Defense with laboratory equipment, immunoassays, and multiplex assay kits. This purchase order represents a modest procurement within Meso Scale Diagnostics' broader federal contracting portfolio, which includes multiple indefinite delivery contracts valued at millions of dollars with the Defense Logistics Agency, Defense Health Agency, and Joint Program Executive Office for Chemical and Biological Defense. The company's core competency in immunoassay development and electrochemiluminescence detection supports biomedical research, infectious disease detection, biodefense initiatives, and diagnostic applications across federal agencies. The B2M assay platform supplied under this contract aligns with the company's expertise in providing multiplex assay capabilities for medical research and diagnostic purposes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | ($150) | 4/29/16 | |
| Not listed | Not listed | $15.8k | 1/28/16 |